Overview

Study to Determine the Effect of Azasite on Corneal Surface Irregularity

Status:
Withdrawn
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of Azasite on patients with corneal surface irregularity (meibomian gland dysfunction).
Phase:
Phase 2
Details
Lead Sponsor:
Philadelphia Eye Associates
Collaborators:
Merck Sharp & Dohme Corp.
Thomas Jefferson University
Treatments:
Azithromycin